Saxenda

FDA-approved GLP-1 medications and their generic active ingredients.

Definition

Once-daily injectable liraglutide 3.0 mg, FDA-approved 2014 for chronic weight management. Shorter half-life (~13 hours) than the once-weekly GLP-1s requires daily dosing.

GLP-1 side effects investigation →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in Drugs and brands

Wegovy
Ozempic
Rybelsus
Zepbound
Mounjaro
Foundayo
Semaglutide
Tirzepatide
Orforglipron
Retatrutide
CagriSema
Cagrilintide
Survodutide
MariTide (Maridebart Cafraglutide)
Ecnoglutide

Looking for more depth?

GLP-1 side effects investigation
Browse the full GLP-1 glossary (51 terms across 8 categories)
Research articles — primary-source deep dives
Tools and calculators
Compare GLP-1 telehealth providers